Advertisement
New Zealand markets closed
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NZD/USD

    0.5927
    -0.0008 (-0.13%)
     
  • NZD/EUR

    0.5541
    +0.0000 (+0.01%)
     
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • OIL

    82.91
    -0.45 (-0.54%)
     
  • GOLD

    2,342.70
    +0.60 (+0.03%)
     
  • NASDAQ

    17,538.68
    +67.21 (+0.38%)
     
  • FTSE

    8,038.30
    -6.51 (-0.08%)
     
  • Dow Jones

    38,374.63
    -129.06 (-0.34%)
     
  • DAX

    18,065.27
    -72.38 (-0.40%)
     
  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • NZD/JPY

    91.8180
    +0.0520 (+0.06%)
     

Behind Dentsply Sirona’s Total Impairment Charges in 2017

Behind Dentsply Sirona’s Total Impairment Charges in 2017

Dentsply Sirona (XRAY) updated its estimates and assumptions during fiscal 2Q17 and underwent an annual impairment test of goodwill. According to company estimates, the goodwill charges associated with some of its technologies segment businesses, including CAD-CAM imaging and its treatment center, came from impairment. The company recorded nearly $1.1 billion in goodwill impairment charges in 2Q17 and $581 million in 4Q17, for a total of ~$1.67 billion in fiscal 2017. Meanwhile, the company undertook an annual impairment assessment of indefinite-lived intangible assets.